¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"bacteriophage phi x 174"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® bacteriophage ÇÑ±Û ¼¼±ÕÆÄÁö, ¹ÚÅ׸®¿ÀÆÄÁö
¼³¸í   
  ¼¼±Õ¿¡ °¨¿°µÇ¾î ±× ¼¼Æ÷ ³»¿¡¼­¸¸ Áõ½ÄÇϴ ¹ÙÀÌ·¯½º ¼¼±ÕÀ» ¼÷ÁַΠÇϴ ¹ÙÀÌ·¯½º·Î ¼¼±Õ¹ÙÀÌ·¯½º¶ó°íµµ ÇÑ´Ù. Áï, ÇÙ»ê°ú ¼Ò¼öÀÇ È¿¼Ò¸¦ ´Ü¹éÁúÀÇ ²®Áú·Î ½Î°í Àִ °£´ÜÇÑ ±¸Á¶À̸ç, °¢°¢ Æ¯Á¤ÀÇ ¼¼±ÕÁ¾¿¡¸¸ °¨¿°ÇÑ´Ù. ¼¼±Õ¿¡ ±â»ýÇϸ砱Õü¸¦ ³ìÀ̴ ¹ÙÀÌ·¯½ºÀÌ´Ù. À¯Àü ÇüÁúÀÇ È­ÇÐÀû Æ¯¼ºÀ» ¿¬±¸Çϴ µ¥¿¡ ¾´´Ù. ÆÄÁö¿¡´Â DNA¿Í RNA ÆÄÁö°¡ ÀÖÀ¸¸ç, ±âÈ£¿Í ¼ýÀڷΠºÐ·ùÇÑ´Ù. ¼¼±Õ¿¡ °¨¿°µÇ¾î ¼¼±ÕÀ» ¿ëÇØ½Ã۴ °ÍÀ» ¿ë±ÕÆÄÁö¶ó ºÎ¸£¸ç, ¼÷ÁÖ¸¦ ³ìÀÌÁö ¾Ê°í ¼÷ÁÖ À¯Àüü¿¡ µé¾î°¡ °øÁ¸Çϴ °ÍÀ» ÅÛÆÛ·¹ÀÌÆ® ÆÄÁö¶ó ºÎ¸¥´Ù. ¶Ç, µ¿½Ä¹° ¼¼Æ÷¿¡ °¨¿°Çϴ ¹ÙÀÌ·¯½º¸¦ °¢°¢ µ¿¹° ¹ÙÀÌ·¯½º-½Ä¹° ¹ÙÀÌ·¯½º¶ó Çϴµ¥ ´ëÇÏ¿© ¼¼±Õ ¹ÙÀÌ·¯½º¶ó°íµµ ÇÑ´Ù. ¼¼±Õ¿©°ú±â¸¦ Åë°úÇϸ砱¤ÇÐÇö¹Ì°æÀ¸·Î´Â Á÷Á¢ º¼ ¼ö ¾ø´Â ¹Ì¼ÒÇÑ ÀÔÀÚÀÌ´Ù. »ì¾ÆÀִ ¼¼Æ÷ ³»¿¡¼­¸¸ Áõ½ÄÀÌ °¡´ÉÇϰí, ´ë»çȰ¼ºÀ» ³ªÅ¸³»´Â Àϵµ ¾ø´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • phi phenomenon
    ÆÄÀÌÇö»ó
  • bacteriophage
    ¹ÚÅ׸®¿ÀÆÄÁö
  • bacteriophage neutralization test
    ¹ÚÅ׸®¿ÀÆÄÁöÁßÈ­½ÃÇè
  • defective bacteriophage
    °á¼Õ¹ÚÅ׸®¿ÀÆÄÁö
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • bacteriophage
    ¼¼±ÕÆÄÁö, ¹ÚÅ׸®¿ÀÆÄÁö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • phi phenomenon
    ÆÄÀÌÇö»ó
  • bacteriophage
    ¼¼±ÕÆÄÁö, ¹ÚÅ׸®¿ÀÆÄÁö
  • bacteriophage typing
    ¹ÚÅ׸®¿ÀÆÄÁöÇüº°, ¹ÚÅ׸®¿ÀÆÄÁöÇü°áÁ¤
  • bacteriophage neutralization test
    ¹ÚÅ׸®¿ÀÆÄÁöÁßÈ­½ÃÇè
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • phi phenomenon
    ÆÄÀÌÇö»ó
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • phi phenomenon
    ÆÄÀÌÇö»ó
  • bacteriophage
    ¼¼±ÕÆÄÁö, ¹ÚÅ׸®¿ÀÆÄÁö.
  • bacteriophage
    ¼¼±ÕºÐÇØ¹ÙÀÌ·¯½º
  • bacteriophage
    ¹ÚÅ׸®¿ÀÆÄÁö
  • bacteriophage neutralization test
    ¹ÚÅ׸®¿ÀÆÄÁö ÁßÈ­½ÃÇè(¡­ñéûúãËúÐ).
  • bacteriophage neutralization test
    ¹ÚÅ׸®¿ÀÆÄÁöÁßÈ­°Ë»ç
  • bacteriophage typing
    ¹ÚÅ׸®¿ÀÆÄÁöÇüº°¹ý
  • bacteriophage typing
    ¼¼±ÕÆÄ¾ÆÁöÇüº°È­(úþܬûù)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • phi angle
    ÆÄÀ̰¢(ÊÇ)
  • bacteriophage
    ¹ÚÅ׸®¿ÀÆäÀÌÁö
  • bacteriophage packaging
    ¹ÚÅ׸®¿ÀÆäÀÌÁö ÆÑÄÉ¡
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
PHI passive hemagglutination inhibition; past history of illness; phosphohexose isomerase; physiological...
PhI Pharmacopoeia Internationalis
f Greek letter phi; magnetic flux; osmotic coefficient
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AM phi Alveolar macrophage
M phi Mononuclear phagocyte
M phi Mouse peritoneal macrophage
M phi Murine peritoneal macrophages
PHI Peptide Histidine Isoleucine
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • bacteriophage neutralization test
    ¹ÚÅ׸®¿À ÆÄ¾ÆÁö ÁßÈ­ ½ÃÇè
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
bacteriophage phi x 174 The type species of the genus microvirus. A prototype of the small virulent DNA coliphages, it is composed of a single strand of supercoiled circular DNA, which on infection, is converted to a double-stranded replicative form by a host enzyme.
(12 Dec 1998)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
phi X 174 <molecular biology> Bacteriophage of E. Coli with a single stranded DNA genome and an icosahedral shell. This was the first DNA phage to be fully sequenced: the genome consists of 10 genes, some of which are overlapping genes.
(18 Nov 1997)
bacteriophage phi 6 Virulent bacteriophage and sole member of the genus cystovirus that infects pseudomonas species. The virion has a segmented genome consisting of three pieces of doubled-stranded DNA and also contains a unique lipid-containing membrane.
(12 Dec 1998)
peptide phi A 27-amino acid peptide with histidine at the n-terminal and isoleucine amide at the c-terminal. The exact amino acid composition of the peptide is species dependent. The peptide is secreted in the intestine, but is found in the nervous system, many organs, and in the majority of peripheral tissues. It has a wide range of biological actions, affecting the cardiovascular, gastrointestinal, respiratory, and central nervous systems.
(12 Dec 1998)
phi 1. The 21st letter of the Greek alphabet.
2. (&Phi;) Symbol for phenyl; potential energy; magnetic flux.
3. (&phi;) Symbol for plane angle; volume fraction; quantum yield; the dihedral angle of rotation about the N-Ca bond associated with a peptide bond.
(05 Mar 2000)
phi phenomenon An illusion of movement, which occurs by means of successive visual impressions at intervals of 1/15 to 1/20 sec; when an occluder is passed from one eye to the other while a small distant light is observed, the light seems to move with the occluder in exophoria, but in an opposite direction in oesophoria.
(05 Mar 2000)
bacteriophage <microbiology, virology> Viruses that have a specific affinity for and infect bacteria.
The bacteriophages that attack Escherichia coli are termed coliphages, examples of these are lambda phage and the T even phages, T2, T4 and T6. Basically, phages consist of a protein coat or capsid enclosing the genetic material, DNA or RNA, that is injected into the bacterium upon infection. In the case of virulent phages all synthesis of host DNA, RNA and proteins ceases and the phage genome is used to direct the synthesis of phage nucleic acids and proteins using the host's transcriptional and translational apparatus.
These phage components then self assemble to form new phage particles. The synthesis of a phage lysozyme leads to rupture of the bacterial cell wall releasing, typically 100-200 phage progeny.
The temperate phages, such as lambda, may also show this lytic cycle when they infect a cell, but more frequently they induce lysogeny.
The study of bacteriophages has been important for our understanding of gene structure and regulation. Lambda has been extensively used as a vector in recombinant DNA studies.
(15 Nov 1997)
bacteriophage 2 depolymerase <enzyme> Hydrolyzes glycolipoproteins and lipopolysaccharides; releases aminosugars
Registry number: EC 3.2.1.-
Synonym: phage 2 depolymerase
(26 Jun 1999)
bacteriophage immunity The state induced in a bacterium by lysogenization, the lysogenic bacterium being insusceptible to further lysogenization or to a lytic cycle by a superinfecting bacteriophage, in contradistinction to bacteriophage resistance.
(05 Mar 2000)
bacteriophage lambda <microbiology, virology> A bacteriophage, or virus which infects bacteria, that infects E. Coli. It has a complex set of regulatory mechanisms to determine whether it will quietly insert its DNA into the bacterial genome to become dormant and to be reproduced whenever the bacterium reproduces (to lysogenize), or whether it will hijack the bacterium's cellular machinery to reproduce itself and prepare to infect more bacteria, causing the bacterium to self-destruct shortly after infection (to lyse).
Lambda is particularly useful to geneticists because parts of it can be used to introduce foreign DNA into the bacterial genome, it is a cloning vector.
(09 Oct 1997)
bacteriophage m13 <microbiology> A bacteriophage (a virus which infects bacteria) that has single-stranded DNA. It is used as a method of obtaining single strands of foreign DNA so that the foreign DNA can be sequenced (that is, the order of its nucleotide bases can be determined). It is also used in procedures to create mutations in vitro (in a test tube rather than within an organism).
(09 Oct 1997)
bacteriophage mu An unassigned species of temperate coliphage, in the family myoviridae, composed of a linear, double-stranded molecule of DNA, which is able to insert itself at random at any point on the host chromosome. It frequently causes a mutation by interrupting the continuity of the bacterial operon at the site of insertion.
(12 Dec 1998)
bacteriophage omicron x174 <microbiology> A bacteriophage (a virus that infects bacteria) which has as its genetic material DNA in single strands instead of the usual double strands. The virus is useful to those who study how DNA replicates.
(09 Oct 1997)
bacteriophage p1 An unassigned species of temperate bacteriophage in the family myoviridae which infects e. Coli. It is the largest of the coliphages and consists of double-stranded DNA, terminally redundant, and circularly permuted.
(12 Dec 1998)
bacteriophage p2 An unassigned species of temperate bacteriophage in the family myoviridae which infects e. Coli. It consists of linear double-stranded DNA with 19-base sticky ends.
(12 Dec 1998)
bacteriophage p22 An unassigned species of temperate bacteriophage in the family podoviridae that infects salmonella species. The genome consists of double-stranded DNA, terminally redundant, and circularly permuted.
(12 Dec 1998)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 1 ÆäÀÌÁö: 1
  • Bacteriophage phi X 174 - »õâ The type species of the genus MICROVIRUS. A prototype of the small virulent DNA coliphages, it is composed of a single strand of supercoiled circular DNA, which on infection, is converted to a double-stranded replicative form by a host enzyme.
    Synonyms : Phage phi X174, phi X174, Phage
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • bacteriophage
    (Àå,¿ÀÁÜ,ÇǼÓÀÇ)»ì±Õ¼Ò
  • Phi Beta Kappa
    ÆÄÀÌ.º£Å¸.Ä«ÆÄŬ·´
  • Phi Bete
    ÆÄÀÌ.º£Å¸.Ä«ÆÄ±Û·´ÀÇ È¸¿ø
  • phi
    ±×¸®½º¾î ¾ËÆÄºªÀÇ 21¹øÂ° ±ÛÀÚ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á